Skip to main content
. 2015 Mar 26;4:146. doi: 10.1186/s40064-015-0923-9

Table 3.

Summary of results for in-house and commercial testing of CDC flax breeder seed

Variety Year sampled # samples # indep. in-house 5.7 g assays Positive in-house assays # indep. commercial 60 g subsamples Positive commercial assays
CDC Arras 2009 1 3 2 5 -
2010 2 8 0 8 -
CDC Bethune 2009 3 9 0 15 -
CDC Gold 2009 1 3 0 1 -
CDC Mons 2009 1 3 0 2 +
2010 5 16 trace 36 +
CDC Normandy 2009 1 3 0 2 +
2010 5 14 3 36 +
CDC Sanctuary 2009 2 6 0 9 -
CDC Sorrel 2009 2 6 0 9 -
CDC Valour 2009 1 3 0 1 -
Flanders 2009 1 3 1 4 -
Somme 2009 1 3 0 4 -
Vimy 2009 1 3 0 1 -

A number of seed samples of CDC varieties were sampled in 2009 and 2010. These samples were tested at a small scale (5.7 g) in-house using the construct- and event-specific assays. Commercial laboratories using the construct-specific assay also tested these same samples. The commercial assay consisted of either a single or four independent 60 g subsamples. Results from the commercial tests were reported as either positive/negative for the subsamples as a whole, or positive/negative/trace for each subsample. As some four-subsample tests were reported as positive or negative, it is not possible to report the number of positive assays. The single positive in-house assay for CDC Mons was very weak and is reported as trace.